BPG is committed to discovery and dissemination of knowledge
Home / Archive / Volume 15, Issue 34
This Article
Citation of this article
Corresponding Author of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
  • Total Article Views (10211)
All Articles published online
The chart showing PDF series, HTML series, Figures (1-2) series, Tables (1-10) series.
Item 
Count 
PDF726
HTML8646
Figures (1-2)577
Tables (1-10)262
 Sum=10211
Sep 14, 2009 (publication date) through Nov 25, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Cited by in CrossRef
For: Aljiffry M, Walsh MJ, Molinari M. Advances in diagnosis, treatment and palliation of cholangiocarcinoma: 1990-2009. World J Gastroenterol 2009; 15(34): 4240-4262 [PMID: 19750567 DOI: 10.3748/wjg.15.4240]
URL: https://www.wjgnet.com/1007-9327/full/v15/i34/4240.htm
Number Citing Articles
1
Jacob Schmidt, Weronika Kuzyniak, Janine Berkholz, Gustav Steinemann, Racheal Ogbodu, Bj�rn Hoffmann, Geraldine Nouailles, Ayşe G�rek, Bianca Nitzsche, Michael H�pfner. Novel zinc‑ and silicon‑phthalocyanines as photosensitizers for photodynamic therapy of cholangiocarcinoma. International Journal of Molecular Medicine 2018;  doi: 10.3892/ijmm.2018.3620
2
Wei On, Muhammad A Saleem, Vinod S Hegade, Matthew T Huggett, Bharat Paranandi, Simon M Everett. Factors predicting 30-day mortality after ERCP in patients with inoperable malignant hilar biliary obstruction: a single tertiary referral centre experience and systematic review. BMJ Open Gastroenterology 2022; 9(1): e000878 doi: 10.1136/bmjgast-2022-000878
3
Kazuto Kozaka, Satoshi Kobayashi, Hiroyuki Takamura, Yasunori Sato, Azusa Kitao, Dai Inoue, Norihide Yoneda, Hidehiro Tajima, Seigo Kinuya, Kenichi Harada, Tetsuo Ohta, Wataru Koda, Osamu Matsui, Toshifumi Gabata. Differences in 18F-FDG Uptake and Expression of Glucose Transporter Between 2 Distinct Subtypes of Mass-Forming Intrahepatic Cholangiocarcinomas. Clinical Nuclear Medicine 2020; 45(6): e267 doi: 10.1097/RLU.0000000000003055
4
Dominic Ku, Reuben Tang, Tony Pang, Henry Pleass, Arthur Richardson, Lawrence Yuen, Vincent Lam. Survival outcomes of hepatic resections in Bismuth‐Corlette type IV cholangiocarcinoma. ANZ Journal of Surgery 2020; 90(9): 1604 doi: 10.1111/ans.15531
5
Lunan Yan, Yan Zhong. Operative Techniques in Liver Resection. 2016; : 191 doi: 10.1007/978-94-017-7411-6_21
6
Ke Ma, Xin Wei, Danfeng Dong, Yinying Wu, Qianqian Geng, Enxiao Li. PD-L1 and PD-1 expression correlate with prognosis in extrahepatic cholangiocarcinoma. Oncology Letters 2017; 14(1): 250 doi: 10.3892/ol.2017.6105
7
Domenico Alvaro, Renato Cannizzaro, Roberto Labianca, Francesca Valvo, Fabio Farinati. Cholangiocarcinoma: A position paper by the Italian Society of Gastroenterology (SIGE), the Italian Association of Hospital Gastroenterology (AIGO), the Italian Association of Medical Oncology (AIOM) and the Italian Association of Oncological Radiotherapy (AIRO). Digestive and Liver Disease 2010; 42(12): 831 doi: 10.1016/j.dld.2010.06.005
8
T. Peter Kingham, Victoria G. Aveson, Alice C. Wei, Jason A. Castellanos, Peter J. Allen, Daniel P. Nussbaum, Yinin Hu, Michael I. D'Angelica. Surgical management of biliary malignancy. Current Problems in Surgery 2021; 58(2): 100854 doi: 10.1016/j.cpsurg.2020.100854
9
Bingyan Liu, Shuo Yan, Yiping Jia, Jun Ma, Shaoqiu Wu, Yuyao Xu, Mingyi Shang, Aiwu Mao. TLR2 promotes human intrahepatic cholangiocarcinoma cell migration and invasion by modulating NF‐κB pathway‐mediated inflammatory responses. The FEBS Journal 2016; 283(20): 3839 doi: 10.1111/febs.13894
10
Tina Boortalary, David Loren. Hepato-Pancreato-Biliary Malignancies. 2022; : 237 doi: 10.1007/978-3-030-41683-6_15
11
Manida Suksawat, Poramate Klanrit, Jutarop Phetcharaburanin, Nisana Namwat, Narong Khuntikeo, Attapol Titapun, Apiwat Jarearnrat, Prakasit Sa-ngiamwibool, Anchalee Techasen, Watcharin Loilome, Gianfranco D. Alpini. In vitro and molecular chemosensitivity in human cholangiocarcinoma tissues. PLOS ONE 2019; 14(9): e0222140 doi: 10.1371/journal.pone.0222140
12
Bradley N. Reames, Timothy M. Pawlik. Surgical Diseases of the Pancreas and Biliary Tree. 2018; : 345 doi: 10.1007/978-981-10-8755-4_14
13
Gui-Li Huang, Qi Luo, Gang Rui, Wei Zhang, Qiu-Yan Zhang, Qing-Xi Chen, Dong-Yan Shen. Oncogenic Activity of Retinoic Acid Receptor γ Is Exhibited through Activation of the Akt/NF-κB and Wnt/β-Catenin Pathways in Cholangiocarcinoma. Molecular and Cellular Biology 2013; 33(17): 3416 doi: 10.1128/MCB.00384-13
14
Mingwu Li, Ming Bai, Xingshun Qi, Kai Li, Zhanxin Yin, Jianhong Wang, Wenbing Wu, Luanluan Zhen, Chuangye He, Daiming Fan, Zhuoli Zhang, Guohong Han. Percutaneous Transhepatic Biliary Metal Stent for Malignant Hilar Obstruction: Results and Predictive Factors for Efficacy in 159 Patients from a Single Center. CardioVascular and Interventional Radiology 2015; 38(3): 709 doi: 10.1007/s00270-014-0992-0
15
Hanisah Guro, Jin Won Kim, YoungRok Choi, Jai Young Cho, Yoo-Seok Yoon, Ho-Seong Han. Multidisciplinary management of intrahepatic cholangiocarcinoma: Current approaches. Surgical Oncology 2017; 26(2): 146 doi: 10.1016/j.suronc.2017.03.001
16
X-F Liu, H Jiang, C-S Zhang, S-P Yu, Z-Q Wang, H-L Su. Targeted Drug Regulation on Methylation of p53—BAX Mitochondrial Apoptosis Pathway Affects the Growth of Cholangiocarcinoma Cells. Journal of International Medical Research 2012; 40(1): 67 doi: 10.1177/147323001204000107
17
Ana Filipa Brito, Marina Ribeiro, Ana Margarida Abrantes, Ana Catarina Mamede, Mafalda Laranjo, João Eduardo Casalta-Lopes, Ana Cristina Gonçalves, Ana Bela Sarmento-Ribeiro, José Guilherme Tralhão, Maria Filomena Botelho. New Approach for Treatment of Primary Liver Tumors: The Role of Quercetin. Nutrition and Cancer 2016; 68(2): 250 doi: 10.1080/01635581.2016.1145245
18
Marianne Sinn, Sven Bischoff, Oliver Nehls, Uwe Pelzer, Fritz von Weizsäcker, Stefan Kubicka, Jens M. Stieler, Karel Caca, Hanno Riess. Biliary Tract Cancer: A Survey Regarding the Current Oncological Daily Care Practice in Germany. Onkologie 2012; 35(12): 755 doi: 10.1159/000345115
19
Qihong Ni, Haolu Wang, Yunhe Zhang, Lijun Qian, Jiachang Chi, Xiaowen Liang, Tao Chen, Jian Wang. MDCT assessment of resectability in hilar cholangiocarcinoma. Abdominal Radiology 2017; 42(3): 851 doi: 10.1007/s00261-016-0943-0
20
Kosin Wirasorn, Thundon Ngamprasertchai, Narong Khuntikeo, Ake Pakkhem, Piti Ungarereevittaya, Jarin Chindaprasirt, Aumkhae Sookprasert. Adjuvant chemotherapy in resectable cholangiocarcinoma patients. Journal of Gastroenterology and Hepatology 2013; 28(12): 1885 doi: 10.1111/jgh.12321
21
Bundit Promraksa, Praewpan Katrun, Jutarop Phetcharaburanin, Yingpinyapat Kittirat, Nisana Namwat, Anchalee Techasen, Jia V. Li, Watcharin Loilome. Metabolic Changes of Cholangiocarcinoma Cells in Response to Coniferyl Alcohol Treatment. Biomolecules 2021; 11(3): 476 doi: 10.3390/biom11030476
22
Z. Y. Huang, X. P. Chen. Hilar Cholangiocarcinoma. 2013; : 211 doi: 10.1007/978-94-007-6473-6_19
23
H. Petrowsky, J.C. Hong. Current Surgical Management of Hilar and Intrahepatic Cholangiocarcinoma: The Role of Resection and Orthotopic Liver Transplantation. Transplantation Proceedings 2009; 41(10): 4023 doi: 10.1016/j.transproceed.2009.11.001
24
B. I. Choi, J. M. Lee. Hilar Cholangiocarcinoma. 2013; : 53 doi: 10.1007/978-94-007-6473-6_5
25
Angela Lamarca, Julien Edeline, Mairéad G McNamara, Richard A Hubner, Masato Nagino, John Bridgewater, John Primrose, Juan W Valle. Current standards and future perspectives in adjuvant treatment for biliary tract cancers. Cancer Treatment Reviews 2020; 84: 101936 doi: 10.1016/j.ctrv.2019.101936
26
Tat’yana Yu. Danzanova, G. T Sinyukova, P. I Lepedatu, N. E Kudashkin. Analysis of the use ultrasound in the complex diagnosis of cholangiocarcinoma. Russian Journal of Oncology 2014; 19(6): 18 doi: 10.17816/onco40093
27
Yu Akazawa, Shoichi Mizuno, Norihiro Fujinami, Toshihiro Suzuki, Yusuke Yoshioka, Takahiro Ochiya, Yasunari Nakamoto, Tetsuya Nakatsura. Usefulness of serum microRNA as a predictive marker of recurrence and prognosis in biliary tract cancer after radical surgery. Scientific Reports 2019; 9(1) doi: 10.1038/s41598-019-42392-7
28
Jin Hyoung Kim, Hyung Jin Won, Yong Moon Shin, Kyung-Ah Kim, Pyo Nyun Kim. Radiofrequency Ablation for the Treatment of Primary Intrahepatic Cholangiocarcinoma. American Journal of Roentgenology 2011; 196(2): W205 doi: 10.2214/AJR.10.4937
29
Zhenzhen Liang, Xin Liu, Qian Zhang, Chunpeng Wang, Yinlong Zhao. Diagnostic value of microRNAs as biomarkers for cholangiocarcinoma. Digestive and Liver Disease 2016; 48(10): 1227 doi: 10.1016/j.dld.2016.07.006
30
Yu Wang, Wei Cui, Wenzhe Fan, Yingqiang Zhang, Wang Yao, Kunbo Huang, Jiaping Li. Percutaneous intraductal radiofrequency ablation in the management of unresectable Bismuth types III and IV hilar cholangiocarcinoma. Oncotarget 2016; 7(33): 53911 doi: 10.18632/oncotarget.10116
31
Min-Hua Chen, Po-Chin Liang, Kai-Chun Chang, Jian-Yuan Huang, Yu-Ting Chang, Fuh-Yu Chang, Jau-Min Wong, Feng-Huei Lin. Prototype of biliary drug-eluting stent with photodynamic and chemotherapy using electrospinning. BioMedical Engineering OnLine 2014; 13(1) doi: 10.1186/1475-925X-13-118
32
Liu Xiaofang, Tang Kun, Yu Shaoping, Wang Zaiqiu, Su Hailong. Correlation between promoter methylation of p14 ARF , TMS1/ASC, and DAPK, and p53 mutation with prognosis in cholangiocarcinoma. World Journal of Surgical Oncology 2012; 10(1) doi: 10.1186/1477-7819-10-5
33
Alessandra Gentilini, Mirella Pastore, Fabio Marra, Chiara Raggi. The Role of Stroma in Cholangiocarcinoma: The Intriguing Interplay between Fibroblastic Component, Immune Cell Subsets and Tumor Epithelium. International Journal of Molecular Sciences 2018; 19(10): 2885 doi: 10.3390/ijms19102885
34
F. Rauchfuss, H. Scheuerlein, M. Götz, Y. Dittmar, R. Voigt, M. Heise, U. Settmacher. Hepatozelluläres Karzinom und Cholangiokarzinom. Der Chirurg 2010; 81(10): 941 doi: 10.1007/s00104-009-1864-z
35
Jin Hyoung Kim, Hyung Jin Won, Yong Moon Shin, Pyo Nyun Kim, Sung-Gyu Lee, Shin Hwang. Radiofrequency ablation for recurrent intrahepatic cholangiocarcinoma after curative resection. European Journal of Radiology 2011; 80(3): e221 doi: 10.1016/j.ejrad.2010.09.019
36
Somsak Likhitrattanapisal, Supeecha Kumkate, Pravech Ajawatanawong, Kanokpan Wongprasert, Rutaiwan Tohtong, Tavan Janvilisri. Dysregulation of microRNA in cholangiocarcinoma identified through a meta-analysis of microRNA profiling. World Journal of Gastroenterology 2020; 26(29): 4356-4371 doi: 10.3748/wjg.v26.i29.4356
37
Francesco Antonio Polistina, Rosabianca Guglielmi, Cristina Baiocchi, Paolo Francescon, Paolo Scalchi, Antonio Febbraro, Giorgio Costantin, Giovanni Ambrosino. Chemoradiation treatment with gemcitabine plus stereotactic body radiotherapy for unresectable, non-metastatic, locally advanced hilar cholangiocarcinoma. Results of a five year experience. Radiotherapy and Oncology 2011; 99(2): 120 doi: 10.1016/j.radonc.2011.05.016
38
Gianluca Rompianesi, Marcello Di Martino, Alex Gordon-Weeks, Roberto Montalti, Roberto Troisi. Liquid biopsy in cholangiocarcinoma: Current status and future perspectives. World Journal of Gastrointestinal Oncology 2021; 13(5): 332-350 doi: 10.4251/wjgo.v13.i5.332
39
Lea Matsuoka, Sophoclis Alexopoulos, Lydia Petrovik, Linda Chan, Yuri Genyk, Rick Selby. Trisectionectomy for Cholangiocarcinoma: Is it Worth It?. The American Surgeon™ 2014; 80(6): 544 doi: 10.1177/000313481408000616
40
Shin Hamada, Kennichi Satoh, Morihisa Hirota, Atsushi Kanno, Kazuyuki Ishida, Jun Umino, Hiromichi Ito, Kazuhiro Kikuta, Kiyoshi Kume, Atsushi Masamune, Yu Katayose, Michiaki Unno, Tooru Shimosegawa. Calcium‐binding protein S100P is a novel diagnostic marker of cholangiocarcinoma. Cancer Science 2011; 102(1): 150 doi: 10.1111/j.1349-7006.2010.01757.x
41
L. Zender, N. P. Malek. Diagnostik und Therapie des cholangiozellulären Karzinoms. Der Internist 2016; 57(12): 1191 doi: 10.1007/s00108-016-0128-5
42
Wen-long Yu, Wen-ming Cong, Yongjie Zhang, Ying Chen, Fei Wang, Guanzhen Yu. Overexpression of ATA1/SLC38A1 Predicts Future Recurrence and Death in Chinese Patients with Hilar Cholangiocarcinoma. Journal of Surgical Research 2011; 171(2): 663 doi: 10.1016/j.jss.2010.03.049
43
Feng Feng, Xuehui Cao, Xueqing Liu, Jianzhang Qin, Shubin Zhang, Qiusheng Li, Jianhua Liu. Laparoscopic resection for Bismuth type III and IV hilar cholangiocarcinoma: How to improve the radicality without direct palpation. Journal of Surgical Oncology 2019; 120(8): 1379 doi: 10.1002/jso.25739
44
N. Ispikoudis, F. Rauchfuss, R. Voigt, H. Scheuerlein, E. Bärthel, Y. Dittmar, U. Settmacher. Chirurgische Therapie von primären Lebertumoren bei Erwachsenen. Der Onkologe 2012; 18(7): 617 doi: 10.1007/s00761-012-2245-7
45
Cemal Yazici, David J Niemeyer, David A Iannitti, Mark W Russo. Hepatocellular carcinoma and cholangiocarcinoma: an update. Expert Review of Gastroenterology & Hepatology 2014; 8(1): 63 doi: 10.1586/17474124.2014.852468
46
Sean Turbeville, Carl S. Hornfeldt, Milind Javle, Eric Tran, Marion Schwartz. Emerging therapies for the treatment of cholangiocarcinoma. International Journal of Hepatobiliary and Pancreatic Diseases 2017; 7(2): 36 doi: 10.5348/ijhpd-2017-72-RA-8
47
L. Chiche, B. Menahem, L. Plard. Tumeurs kystiques et non kystiques biliaires. EMC - Traité de médecine AKOS 2013; 8(1): 1 doi: 10.1016/S1634-6939(12)54655-7
48
Constantin A Dasanu, Shounak Majumder, Guru Trikudanathan. Emerging pharmacotherapeutic strategies for cholangiocarcinoma. Expert Opinion on Pharmacotherapy 2011; 12(12): 1865 doi: 10.1517/14656566.2011.583919
49
Kun Cao, Bo Li, Ye-Wei Zhang, Hui Song, Yi-Gang Chen, Yong-Jun Gong, Hai-Yang Li, Shi Zuo. miR-29b restrains cholangiocarcinoma progression by relieving DNMT3B-mediated repression of CDKN2B expression. Aging 2021; 13(4): 6055 doi: 10.18632/aging.202549
50
Tina Boortalary, David Loren. Hepato-Pancreato-Biliary Malignancies. 2021; : 1 doi: 10.1007/978-3-030-37482-2_15-1
51
Junji Furuse, Takuji Okusaka, John Bridgewater, Masanori Taketsuna, Harpreet Wasan, Minori Koshiji, Juan Valle. Lessons from the comparison of two randomized clinical trials using gemcitabine and cisplatin for advanced biliary tract cancer. Critical Reviews in Oncology/Hematology 2011; 80(1): 31 doi: 10.1016/j.critrevonc.2010.10.009
52
Brendan Boland, Amanda Kim, Nicholas Nissen, Steve Colquhoun. Cholangiocarcinoma: Aggressive Surgical Intervention Remains Justified. The American Surgeon™ 2012; 78(2): 157 doi: 10.1177/000313481207800231
53
Michela Squadroni, Luca Tondulli, Gemma Gatta, Stefania Mosconi, Giordano Beretta, Roberto Labianca. Cholangiocarcinoma. Critical Reviews in Oncology/Hematology 2017; 116: 11 doi: 10.1016/j.critrevonc.2016.11.012
54
Yang Yu, Yan Chen, Jianxia Ma, Xiaofeng Yu, Guanzhen Yu, Zhaoshen Li. SPARCL1 is a novel predictor of tumor recurrence and survival in hilar cholangiocarcinoma. Tumor Biology 2016; 37(3): 4159 doi: 10.1007/s13277-015-4206-4
55
Matthew Cwinn, Gordon Walsh, Sheikh Hasibur Rahman, Michele Molinari. The Geography of Primary Hepatic Neoplasms Treatments in Canada: Changes in Latitudes and Changes in Attitudes. Canadian Journal of Gastroenterology and Hepatology 2017; 2017: 1 doi: 10.1155/2017/9365657
56
L. Chiche, B. Menahem, L. Plard. Tumori cistici e non cistici biliari. EMC - AKOS - Trattato di Medicina 2013; 15(2): 1 doi: 10.1016/S1634-7358(13)64592-1
57
Jan B. Kuhlmann, Wulf Euringer, Hans C. Spangenberg, Matthias Breidert, Hubert E. Blum, Jan Harder, Richard Fischer. Treatment of unresectable cholangiocarcinoma. European Journal of Gastroenterology & Hepatology 2012; : 1 doi: 10.1097/MEG.0b013e3283502241
58
Reiji Sugita. Magnetic resonance evaluations of biliary malignancy and condition at high-risk for biliary malignancy: Current status. World Journal of Hepatology 2013; 5(12): 654-665 doi: 10.4254/wjh.v5.i12.654
59
Sudipta Saha, Vivek Gautam, Manoj Andley, Ashok Kumar, Ajay Kumar. Dilated biliary system. Saudi Journal of Gastroenterology 2012; 18(3): 223 doi: 10.4103/1319-3767.96469
60
Michelle A. Anderson, Vasu Appalaneni, Tamir Ben-Menachem, G. Anton Decker, Dayna S. Early, John A. Evans, Robert D. Fanelli, Deborah A. Fisher, Laurel R. Fisher, Norio Fukami, Joo Ha Hwang, Steven O. Ikenberry, Rajeev Jain, Terry L. Jue, Khalid Khan, Mary Lee Krinsky, Phyllis M. Malpas, John T. Maple, Ravi N. Sharaf, Amandeep K. Shergill, Jason A. Dominitz, Brooks D. Cash. The role of endoscopy in the evaluation and treatment of patients with biliary neoplasia. Gastrointestinal Endoscopy 2013; 77(2): 167 doi: 10.1016/j.gie.2012.09.029
61
Jens Sperling, Christoph Justinger, Jochen Schuld, Christian Ziemann, Roland Seidel, Otto Kollmar. Intrahepatic cholangiocarcinoma in a transplant liver - selective internal radiation therapy followed by right hemihepatectomy: report of a case. World Journal of Surgical Oncology 2014; 12(1) doi: 10.1186/1477-7819-12-198
62
Phonepasong Ayé Soukhathammavong, Youthanavanh Vonghachack, Christoph Hatz, Kongsap Akkhavong, Peter Odermatt. Suspected cases of cholangiocarcinoma seen in reference hospitals in Lao People's Democratic Republic. Parasitology International 2017; 66(4): 510 doi: 10.1016/j.parint.2016.11.011
63
Jan Grendar, Petra Grendarova, Richie Sinha, Elijah Dixon. Neoadjuvant therapy for downstaging of locally advanced hilar cholangiocarcinoma: a systematic review. HPB 2014; 16(4): 297 doi: 10.1111/hpb.12150
64
Jinyang Gu, Jianling Bai, Xiaolei Shi, Jianxin Zhou, Yudong Qiu, Yafu Wu, Chunping Jiang, Xitai Sun, Fanggui Xu, Yue Zhang, Yitao Ding. Efficacy and safety of liver transplantation in patients with cholangiocarcinoma: A systematic review and meta‐analysis. International Journal of Cancer 2012; 130(9): 2155 doi: 10.1002/ijc.26019
65
Mehdi Mohamadnejad, John M. DeWitt, Stuart Sherman, Julia K. LeBlanc, Henry A. Pitt, Michael G. House, Kelly J. Jones, Evan L. Fogel, Lee McHenry, James L. Watkins, Gregory A. Cote, Glen A. Lehman, Mohammad A. Al-Haddad. Role of EUS for preoperative evaluation of cholangiocarcinoma: a large single-center experience. Gastrointestinal Endoscopy 2011; 73(1): 71 doi: 10.1016/j.gie.2010.08.050
66
Jesper B. Andersen, Bart Spee, Boris R. Blechacz, Itzhak Avital, Mina Komuta, Andrew Barbour, Elizabeth A. Conner, Matthew C. Gillen, Tania Roskams, Lewis R. Roberts, Valentina M. Factor, Snorri S. Thorgeirsson. Genomic and Genetic Characterization of Cholangiocarcinoma Identifies Therapeutic Targets for Tyrosine Kinase Inhibitors. Gastroenterology 2012; 142(4): 1021 doi: 10.1053/j.gastro.2011.12.005
67
Suzanne C. Schiffman, Tiffany Metzger, Gregory Dubel, Tomas Andrasina, Ivan Kralj, Cliff Tatum, Kelly M. McMasters, Charles R. Scoggins, Robert C. G. Martin. Precision Hepatic Arterial Irinotecan Therapy in the Treatment of Unresectable Intrahepatic Cholangiocellular Carcinoma: Optimal Tolerance and Prolonged Overall Survival. Annals of Surgical Oncology 2011; 18(2): 431 doi: 10.1245/s10434-010-1333-4
68
Kichang Han, Heung Kyu Ko, Kyung Won Kim, Hyung Jin Won, Yong Moon Shin, Pyo Nyun Kim. Radiofrequency Ablation in the Treatment of Unresectable Intrahepatic Cholangiocarcinoma: Systematic Review and Meta-Analysis. Journal of Vascular and Interventional Radiology 2015; 26(7): 943 doi: 10.1016/j.jvir.2015.02.024
69
Arjun Nanda, Jason M. Brown, Stephen H. Berger, Melinda M. Lewis, Emily G. Barr Fritcher, Gregory J. Gores, Steven A. Keilin, Kevin E. Woods, Qiang Cai, Field F. Willingham. Triple modality testing by endoscopic retrograde cholangiopancreatography for the diagnosis of cholangiocarcinoma. Therapeutic Advances in Gastroenterology 2015; 8(2): 56 doi: 10.1177/1756283X14564674
70
Huihong Liang, Zhenwei Peng, Liangqi Cao, Shikun Qian, Zili Shao. Metal Stenting with or without Endobiliary Radiofrequency Ablation for Unresectable Extrahepatic Cholangiocarcinoma. Journal of Cancer Therapy 2015; 6(11): 981 doi: 10.4236/jct.2015.611106
71
Ornella Moschovaki-Zeiger, Nikolaos-Achilleas Arkoudis, Athanasios Giannakis, Stavros Grigoriadis, Fotis Anagnostopoulos, Stavros Spiliopoulos. Biodegradable Microspheres for Transarterial Chemoembolization in Malignant Liver Disease. Medicina 2024; 60(4): 678 doi: 10.3390/medicina60040678
72
Dong Kuang, Guo-Ping Wang. Hilar cholangiocarcinoma: Pathology and tumor biology. Frontiers of Medicine in China 2010; 4(4): 371 doi: 10.1007/s11684-010-0130-6
73
Celso Matos, Eva Serrao, Maria Antonieta Bali. Magnetic Resonance Imaging of Biliary Tumors. Magnetic Resonance Imaging Clinics of North America 2010; 18(3): 477 doi: 10.1016/j.mric.2010.08.004
74
Hyun-Ho Choi, Ok-Ran Shin, Hyung-Keun Kim, Bu-Seok Jeon, Yong-Won Park, Sang-Woo Kim, Sung-Soo Kim, Hiun-Suk Chae, Soo Vin Lee. Efficacy of Endobiliary Radiofrequency Ablation using a Novel Endoluminal Radiofrequency Ablation Catheter in a Swine Model. Journal of Investigative Surgery 2019; 32(8): 731 doi: 10.1080/08941939.2018.1489566
75
Chiara Raggi, Karim Fiaccadori, Mirella Pastore, Margherita Correnti, Benedetta Piombanti, Elisa Forti, Nadia Navari, Giovanni Abbadessa, Terence Hall, Annarita Destro, Luca Di Tommaso, Massimo Roncalli, Fanyin Meng, Shannon Glaser, Elisabetta Rovida, Caterina Peraldo-Neia, Paula Olaizola, Jesus M. Banales, Alessio Gerussi, Alessandra Elvevi, Michele Droz dit Busset, Sherrie Bhoori, Vincenzo Mazzaferro, Gianfranco Alpini, Fabio Marra, Pietro Invernizzi. Antitumor Activity of a Novel Fibroblast Growth Factor Receptor Inhibitor for Intrahepatic Cholangiocarcinoma. The American Journal of Pathology 2019; 189(10): 2090 doi: 10.1016/j.ajpath.2019.06.007
76
Omar Hyder, J. Wallis Marsh, Riad Salem, Elena N. Petre, Sanjeeva Kalva, Eleni Liapi, David Cosgrove, Donielle Neal, Ihab Kamel, Andrew X. Zhu, Constantinos T. Sofocleous, Jean-Francois H. Geschwind, Timothy M. Pawlik. Intra-arterial Therapy for Advanced Intrahepatic Cholangiocarcinoma: A Multi-institutional Analysis. Annals of Surgical Oncology 2013; 20(12): 3779 doi: 10.1245/s10434-013-3127-y
77
Marco Massani, Luca Bonariol, Tommaso Stecca. Hepatic Arterial Infusion Chemotherapy for Unresectable Intrahepatic Cholangiocarcinoma, a Comprehensive Review. Journal of Clinical Medicine 2021; 10(12): 2552 doi: 10.3390/jcm10122552
78
Young-Ho Kim, Eun-Kyung Hong, Sun-Young Kong, Sung-Sik Han, Seoung-Hoon Kim, Je-Keun Rhee, Soo-Kyung Hwang, Sang-Jae Park, Tae-Min Kim. Two classes of intrahepatic cholangiocarcinoma defined by relative abundance of mutations and copy number alterations. Oncotarget 2016; 7(17): 23825 doi: 10.18632/oncotarget.8183
79
Albrecht Reichle, Frank Klebl, Klaus Bross, Frank Kullmann, Peter Wild, Anna Berand, Stefan W. Krause, Jürgen Schölmerich, Reinhard Andreesen. From Molecular to Modular Tumor Therapy. 2010; : 341 doi: 10.1007/978-90-481-9531-2_16
80
Ivo Boškoski, Tommaso Schepis, Andrea Tringali, Pietro Familiari, Vincenzo Bove, Fabia Attili, Rosario Landi, Vincenzo Perri, Guido Costamagna. Personalized Endoscopy in Complex Malignant Hilar Biliary Strictures. Journal of Personalized Medicine 2021; 11(2): 78 doi: 10.3390/jpm11020078
81
Hasaya Dokduang, Anchalee Techasen, Nisana Namwat, Narong Khuntikeo, Chawalit Pairojkul, Yoshinori Murakami, Watcharin Loilome, Puangrat Yongvanit. STATs profiling reveals predominantly‐activated STAT3 in cholangiocarcinoma genesis and progression. Journal of Hepato-Biliary-Pancreatic Sciences 2014; 21(10): 767 doi: 10.1002/jhbp.131
82
Vaibhav Wadhwa, Nicole Patel, Dheera Grover, Faisal S. Ali, Nirav Thosani. Interventional gastroenterology in oncology. CA: A Cancer Journal for Clinicians 2023; 73(3): 286 doi: 10.3322/caac.21766
83
Kengo Shigehara, Shigeki Yokomuro, Osamu Ishibashi, Yoshiaki Mizuguchi, Yasuo Arima, Yutaka Kawahigashi, Tomohiro Kanda, Ichiro Akagi, Takashi Tajiri, Hiroshi Yoshida, Toshihiro Takizawa, Eiji Uchida, Carlo Gaetano. Real-Time PCR-Based Analysis of the Human Bile MicroRNAome Identifies miR-9 as a Potential Diagnostic Biomarker for Biliary Tract Cancer. PLoS ONE 2011; 6(8): e23584 doi: 10.1371/journal.pone.0023584
84
Ni Wang, Chongguo Zhang, Wulin Wang, Jie Liu, Yang Yu, You Li, Mingjiong Zhang, Xianxiu Ge, Quanpeng Li, Lin Miao. Long noncoding RNA DANCR regulates proliferation and migration by epigenetically silencing FBP1 in tumorigenesis of cholangiocarcinoma. Cell Death & Disease 2019; 10(8) doi: 10.1038/s41419-019-1810-z
85
Caroline D.M. Witjes, Henrike E. Karim‐Kos, Otto Visser, Esther de Vries, Jan N.M. IJzermans, Robert A. de Man, Jan Willem W. Coebergh, Cornelis Verhoef. Intrahepatic cholangiocarcinoma in a low endemic area: rising incidence and improved survival. HPB 2012; 14(11): 777 doi: 10.1111/j.1477-2574.2012.00536.x
86
Irving Waxman, Mariano Gonzalez-Haba. Difficult Decisions in Hepatobiliary and Pancreatic Surgery. Difficult Decisions in Surgery: An Evidence-Based Approach 2016; : 329 doi: 10.1007/978-3-319-27365-5_29
87
D Azoulay, G Pascal, C Salloum, R Adam, D Castaing, N Tranecol. Vascular reconstruction combined with liver resection for malignant tumours. British Journal of Surgery 2013; 100(13): 1764 doi: 10.1002/bjs.9295
88
R Jeffrey. Multi-Detector CT Imaging. 2013; : 41 doi: 10.1201/b15604-4
89
In Gyu Hwang, Hong Suk Song, Myung Ah Lee, Eun Mi Nam, Joohan Lim, Kyung Hee Lee, Kyu Taek Lee, Dae Young Zang, Joung-Soon Jang. Treatment outcomes of gemcitabine alone versus gemcitabine plus platinum for advanced biliary tract cancer: a Korean Cancer Study Group retrospective analysis. Cancer Chemotherapy and Pharmacology 2014; 74(6): 1291 doi: 10.1007/s00280-014-2608-4
90
Haiying Zhao, Fuquan Yang, Wenyan Zhao, Chunjv Zhang, Jingang Liu. Fascin Overexpression Promotes Cholangiocarcinoma RBE Cell Proliferation, Migration, and Invasion. Technology in Cancer Research & Treatment 2016; 15(2): 322 doi: 10.1177/1533034615580696
91
Mahesh Kr Goenka, Usha Goenka. Palliation: Hilar cholangiocarcinoma. World Journal of Hepatology 2014; 6(8): 559-569 doi: 10.4254/wjh.v6.i8.559
92
HAIXIA YANG, JIUPENG ZHOU, XIN WEI, FAN WANG, HUADONG ZHAO, ENXIAO LI. Survival outcomes and progonostic factors of extrahepatic cholangiocarcinoma patients following surgical resection: Adjuvant therapy is a favorable prognostic factor. Molecular and Clinical Oncology 2014; 2(6): 1069 doi: 10.3892/mco.2014.377
93
Sun Och Yoon, Tae Joo Jeon, Joon Seong Park, Yong Hoon Ryu, Jae-Hoon Lee, Jung Sik Yoo, Jae Keun Kim, Dong Sup Yoon, Eun Ji Oh. Analysis of the Roles of Glucose Transporter 1 and Hexokinase 2 in the Metabolism of Glucose by Extrahepatic Bile Duct Cancer Cells. Clinical Nuclear Medicine 2015; 40(3): e178 doi: 10.1097/RLU.0000000000000640
94
Jaime Feliu, Javier Sastre, Joan Maurel, Dolores Isla. Hepatocellular and biliary tract carcinomas: SEOM clinical guidelines. Clinical and Translational Oncology 2011; 13(8): 536 doi: 10.1007/s12094-011-0694-x
95
Ana Brito, Ana Abrantes, Ricardo Teixo, Ana Pires, Ana Ribeiro, Rafael Ferreira, Alexandra Fernandes, Tiago Puga, Mafalda Laranjo, Francisco Caramelo, Ilka Boin, Douglas Jefferson, Ana Gon�alves, Ricardo Martins, Joana Rodrigues, Ilda Ribeiro, Joana Barbosa De Melo, Ana Sarmento-Ribeiro, Isabel Carreira, Doroteia Souza, Jos� Guilherme Tralh�o, Maria Botelho. Iodine‑131 metabolic radiotherapy leads to cell death and genomic alterations through NIS overexpression on cholangiocarcinoma. International Journal of Oncology 2020;  doi: 10.3892/ijo.2020.4957
96
Sirinya Sitthirak, Manida Suksawat, Jutarop Phetcharaburanin, Arporn Wangwiwatsin, Poramate Klanrit, Nisana Namwat, Narong Khuntikeo, Attapol Titapun, Apiwat Jarearnrat, Sakkarn Sangkhamanon, Watcharin Loilome. Chemotherapeutic resistant cholangiocarcinoma displayed distinct intratumoral microbial composition and metabolic profiles. PeerJ 2022; 10: e13876 doi: 10.7717/peerj.13876
97
Georgios Charalampopoulos, Roberto Iezzi, Maria Tsitskari, Argyro Mazioti, Olympia Papakonstantinou, Alexis Kelekis, Nikolaos Kelekis, Dimitrios Filippiadis. Role of Percutaneous Ablation in the Management of Intrahepatic Cholangiocarcinoma. Medicina 2023; 59(7): 1186 doi: 10.3390/medicina59071186
98
Jinmok Bae, Dong Woo Shin, Kwang Bum Cho, Keun Soo Ahn, Tae-Seok Kim, Yong Hoon Kim, Koo Jeong Kang. Survival outcome of surgical resection compared to non-resection for Bismuth type IV perihilar cholangiocarcinoma. Langenbeck's Archives of Surgery 2023; 408(1) doi: 10.1007/s00423-023-02965-7
99
Sun-young Park, Jin Hyoung Kim, Hyung Jin Won, Yong Moon Shin, Pyo Nyun Kim. Radiofrequency Ablation of Hepatic Metastases After Curative Resection of Extrahepatic Cholangiocarcinoma. American Journal of Roentgenology 2011; 197(6): W1129 doi: 10.2214/AJR.11.6420
100
Vennila Padmanaban, Samantha M. Ruff, Timothy M. Pawlik. Multi-Disciplinary Care of Hilar Cholangiocarcinoma: Review of Guidelines and Recent Advancements. Cancers 2023; 16(1): 30 doi: 10.3390/cancers16010030
101
YouJin Lee, DongWook Choi, Sunjong Han, In Woong Han, Jin Seok Heo, Seong Ho Choi. Comparison analysis of left-side versus right-side resection in bismuth type III hilar cholangiocarcinoma. Annals of Hepato-Biliary-Pancreatic Surgery 2018; 22(4): 350 doi: 10.14701/ahbps.2018.22.4.350
102
Zeki Akca, Hasan Mutlu, Abdulsamet Erden, Abdullah Buyukcelik, Yasemin Benderli Cihan, Sema Sezgin Goksu, Tuncay Aslan, Emel Yaman Sezer, Ali Inal. Survival Analysis of Biliary Tract Cancer Cases in Turkey. Asian Pacific Journal of Cancer Prevention 2014; 15(15): 6025 doi: 10.7314/APJCP.2014.15.15.6025
103
Trevor A. Flood, Dhanpat Jain, E. Celia Marginean. Malignant tumours of gallbladder and extrahepatic bile ducts. Diagnostic Histopathology 2010; 16(8): 360 doi: 10.1016/j.mpdhp.2010.06.003
104
Junji Furuse, Takuji Okusaka. Targeted Therapy for Biliary Tract Cancer. Cancers 2011; 3(2): 2243 doi: 10.3390/cancers3022243
105
G.‐Q. Zhu, K.‐Q. Shi, J. You, H. Zou, Y.‐Q. Lin, L.‐R. Wang, M. Braddock, Y.‐P. Chen, M.‐H. Zheng. Systematic review with network meta‐analysis: adjuvant therapy for resected biliary tract cancer. Alimentary Pharmacology & Therapeutics 2014; 40(7): 759 doi: 10.1111/apt.12900
106
Byung Ihn Choi. Diseases of the Abdomen and Pelvis 2014–2017. 2014; : 111 doi: 10.1007/978-88-470-5659-6_13
107
学河 朱. Typing, Risk Factors and Related Treatments of Cholangiocarcinoma. Advances in Clinical Medicine 2014; 4(04): 74 doi: 10.12677/ACM.2014.44014
108
X. Y. Yin. Hilar Cholangiocarcinoma. 2013; : 91 doi: 10.1007/978-94-007-6473-6_8
109
Massimiliano Cadamuro, Tommaso Stecca, Simone Brivio, Valeria Mariotti, Romina Fiorotto, Carlo Spirli, Mario Strazzabosco, Luca Fabris. The deleterious interplay between tumor epithelia and stroma in cholangiocarcinoma. Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease 2018; 1864(4): 1435 doi: 10.1016/j.bbadis.2017.07.028
110
F. Bibeau, N. Guedj. Tumeurs des voies biliaires: difficultés et pièges diagnostiques en anatomie pathologique. Oncologie 2012; 14(3): 133 doi: 10.1007/s10269-012-2136-y
111
J. Y. H. Chan, K. K. H. Lee, Y. L. Chui. Hilar Cholangiocarcinoma. 2013; : 111 doi: 10.1007/978-94-007-6473-6_10
112
Tobias Kiesslich, Daniel Neureiter, Gernot W Wolkersdörfer, Kristjan Plaetzer, Frieder Berr. Advances in Photodynamic Therapy for the Treatment of Hilar Biliary Tract Cancer. Future Oncology 2010; 6(12): 1925 doi: 10.2217/fon.10.147
113
Sarah B. Fisher, Sameer H. Patel, David A. Kooby, Sharon Weber, Mark Bloomston, Clifford Cho, Ioannis Hatzaras, Carl Schmidt, Emily Winslow, Charles A. Staley, Shishir K. Maithel. Lymphovascular and perineural invasion as selection criteria for adjuvant therapy in intrahepatic cholangiocarcinoma: a multi-institution analysis. HPB 2012; 14(8): 514 doi: 10.1111/j.1477-2574.2012.00489.x
114
Zhi‐Hua Li, Qi‐Bin Tang, Jie Wang, Ling Zhou, Wen‐lin Huang, Ran‐Yi Liu, Ru‐Fu Chen. Hepatitis C virus core protein induces malignant transformation of biliary epithelial cells by activating nuclear factor‐κB pathway. Journal of Gastroenterology and Hepatology 2010; 25(7): 1315 doi: 10.1111/j.1440-1746.2009.06201.x
115
John G. Phillips, John A. Wolfgang, Theodore S. Hong. Biliary Tract and Gallbladder Cancer. Medical Radiology 2014; : 311 doi: 10.1007/978-3-642-40558-7_21
116
Liwei Pang, Shuodong Wu, Jing Kong. Comparison of Efficacy and Safety between Endoscopic Retrograde Cholangiopancreatography and Percutaneous Transhepatic Cholangial Drainage for the Treatment of Malignant Obstructive Jaundice: A Systematic Review and Meta-Analysis. Digestion 2023; 104(2): 85 doi: 10.1159/000528020
117
Junichi Shindoh, Giuseppe Zimmitti, Jean-Nicolas Vauthey. Biliary Tract and Gallbladder Cancer. Medical Radiology 2014; : 253 doi: 10.1007/978-3-642-40558-7_16
118
Tiffany Priyanthi Hennedige, Wee Thong Neo, Sudhakar Kundapur Venkatesh. Imaging of malignancies of the biliary tract- an update. Cancer Imaging 2014; 14(1) doi: 10.1186/1470-7330-14-14
119
M. Grunnet, M. Mau-Sørensen. Serum tumor markers in bile duct cancer – a review. Biomarkers 2014; 19(6): 437 doi: 10.3109/1354750X.2014.923048
120
Anusha Kalbasi, Edgar Ben-Josef. Radiation Therapy for Gastrointestinal Cancers. 2017; : 131 doi: 10.1007/978-3-319-43115-4_11
121
Min-hang Zhou, Hong-wei Zhou, Mo Liu, Jun-zhong Sun. The role of miR-92b in cholangiocarcinoma patients. The International Journal of Biological Markers 2018; 33(3): 293 doi: 10.1177/1724600817751524
122
Dongwook Oh, Junyong Chong, Tae Jun Song, Do Hyun Park, Sang Soo Lee, Dong‐Wan Seo, Sung Koo Lee, Myung‐Hwan Kim. The usefulness of endobiliary radiofrequency ablation before metal stent placement in unresectable malignant hilar obstruction. Journal of Gastroenterology and Hepatology 2022; 37(11): 2083 doi: 10.1111/jgh.15967
123
Yongjun Chen, Jian Luo, Rui Tian, Huawen Sun, Shengquan Zou. miR-373 Negatively Regulates Methyl-CpG-Binding Domain Protein 2 (MBD2) in Hilar Cholangiocarcinoma. Digestive Diseases and Sciences 2011; 56(6): 1693 doi: 10.1007/s10620-010-1481-1
124
S.-Y. Park, J.H. Kim, H.-J. Yoon, I.-S. Lee, H.-K. Yoon, K.-P. Kim. Transarterial chemoembolization versus supportive therapy in the palliative treatment of unresectable intrahepatic cholangiocarcinoma. Clinical Radiology 2011; 66(4): 322 doi: 10.1016/j.crad.2010.11.002
125
A Höblinger, T Gerhardt, MA González-Carmona, R Hüneburg, T Sauerbruch, V Schmitz. Feasibility and safety of long-term photodynamic therapy (PDT) in the palliative treatment of patients with hilar cholangiocarcinoma. European Journal of Medical Research 2011; 16(9): 391 doi: 10.1186/2047-783X-16-9-391
126
Hongwei Sun, Ying Li, Hongru Kong, Shengjie Dai, Haixin Qian. Dysregulation of KCNQ1OT1 promotes cholangiocarcinoma progression via miR-140-5p/SOX4 axis. Archives of Biochemistry and Biophysics 2018; 658: 7 doi: 10.1016/j.abb.2018.09.019
127
Giada Rossignoli, Alessandro Grottesi, Giovanni Bisello, Riccardo Montioli, Carla Borri Voltattorni, Alessandro Paiardini, Mariarita Bertoldi. Cysteine 180 Is a Redox Sensor Modulating the Activity of Human Pyridoxal 5′-Phosphate Histidine Decarboxylase. Biochemistry 2018; 57(44): 6336 doi: 10.1021/acs.biochem.8b00625
128
Michael G. House, Keith D. Lillemoe. Handbook of Liver Disease. 2018; : 499 doi: 10.1016/B978-0-323-47874-8.00036-5
129
Anna Melissa Schlitter, Irene Esposito. Definition of Microscopic Tumor Clearance (R0) in Pancreatic Cancer Resections. Cancers 2010; 2(4): 2001 doi: 10.3390/cancers2042001
130
MARCO MASSANI, TOMMASO STECCA, LUCA FABRIS, EZIO CARATOZZOLO, CESARE RUFFOLO, ALBERTO FURLANETTO, STUART MORTON, MASSIMILIANO CADAMURO, MARIO STRAZZABOSCO, NICOLÒ BASSI. Isolation and characterization of biliary epithelial and stromal cells from resected human cholangiocarcinoma: A novel in vitro model to study tumor-stroma interactions. Oncology Reports 2013; 30(3): 1143 doi: 10.3892/or.2013.2568
131
N. S. Skreptsova, S. O. Stepanov, L. A. Mitina, A. D. Kaprin, A. A. Kostin, A. N. Vostrov, D. V. Dolgacheva, N. V. Evtyagina. Modern ultrasound diagnosis of cholangiocarcinoma (Klatskin's tumor). Onkologiya. Zhurnal imeni P.A.Gertsena 2018; 7(4): 38 doi: 10.17116/onkolog20187438
132
Ying Wang, Nayiyuan Wu, Xia Luo, Xiaoyun Zhang, Qianjin Liao, Jing Wang. SOX2OT, a novel tumor-related long non-coding RNA. Biomedicine & Pharmacotherapy 2020; 123: 109725 doi: 10.1016/j.biopha.2019.109725
133
Jing-Hong Hu, Jui-hsiang Tang, Cheng-Hui Lin, Yin-Yi Chu, Nai-Jen Liu. Preoperative Staging of Cholangiocarcinoma and Biliary Carcinoma using 18F-Fluorodeoxyglucose Positron Emission Tomography: A Meta-Analysis. Journal of Investigative Medicine 2018; 66(1): 52 doi: 10.1136/jim-2017-000472
134
Yoko Yashima, Shinpei Sato, Toshihiro Kawai, Takafumi Sugimoto, Takahisa Sato, Miho Kanda, Shuntaro Obi. Intraarterial 5-fluorouracil and interferon therapy is safe and effective for nonresectable biliary tract adenocarcinoma. Hepatology International 2015; 9(1): 142 doi: 10.1007/s12072-014-9583-z
135
Yongjia Yan, Ning Lu, Weijun Tian, Tong Liu. Evolution of Surgery for Klatskin Tumor Demonstrates Improved Outcome: A Single Center Analysis. Tumori Journal 2014; 100(6): e250 doi: 10.1177/1778.19288
136
Kritiya Butthongkomvong, Ekaphop Sirachainan, Supattra Jhankumpha, Surang Kumdang, On-Usa Sukhontharot. Treatment Outcome of Palliative Chemotherapy in Inoperable Cholangiocarcinoma in Thailand. Asian Pacific Journal of Cancer Prevention 2013; 14(6): 3565 doi: 10.7314/APJCP.2013.14.6.3565
137
Vijayadershan Muppidi, Sreenath Meegada, James D Eaton, Satheesh P Nair, Rajanshu Verma. Recurrent Cholangiocarcinoma Presenting as Sister Mary Joseph Nodule After Liver Transplantation. Cureus 2020;  doi: 10.7759/cureus.11673
138
D.P.S. Sohal, K. Mykulowycz, T. Uehara, U.R. Teitelbaum, N. Damjanov, B.J. Giantonio, M. Carberry, P. Wissel, M. Jacobs-Small, P.J. O'Dwyer, A. Sepulveda, W. Sun. A phase II trial of gemcitabine, irinotecan and panitumumab in advanced cholangiocarcinoma. Annals of Oncology 2013; 24(12): 3061 doi: 10.1093/annonc/mdt416
139
Steven Reitz, Kristine Slam, Lowell W. Chambers. Biliary, Pancreatic, and Hepatic Imaging for the General Surgeon. Surgical Clinics of North America 2011; 91(1): 59 doi: 10.1016/j.suc.2010.10.005
140
Valeriy V. Boyko, Yuriy V. Avdosyev, Anastasiia L. Sochnieva, Denys O. Yevtushenko, Dmitro V. Minukhin. PERCUTANEOUS TRANSHEPATIC CHOLANGIOGRAPHY IN THE DIAGNOSTICS OF COMMON BILE DUCT DISEASES COMPLICATED BY OBSTRUCTIVE JAUNDICE*. Emergency Medical Service 2021; 8(2): 62 doi: 10.36740/EmeMS202102102
141
Steven P. O’Hara, Sergio A. Gradilone, Tetyana V. Masyuk, James H. Tabibian, Nicholas F. LaRusso. MicroRNAs in Cholangiopathies. Current Pathobiology Reports 2014; 2(3): 133 doi: 10.1007/s40139-014-0048-9
142
Qiang Huang, Lei Liu, Chen-Hai Liu, Feng Shao, Fang Xie, Chuan-Hai Zhang, San-Yuan Hu. Expression of Smad7 in Cholangiocarcinoma: Prognostic Significance and Implications for Tumor Metastasis. Asian Pacific Journal of Cancer Prevention 2012; 13(10): 5161 doi: 10.7314/APJCP.2012.13.10.5161
143
Andrew M. Gaya. Stereotactic Body Radiotherapy. 2015; : 149 doi: 10.1007/978-0-85729-597-2_9
144
Yi Xu, Yue Yao, Kaiming Leng, Zhenglong Li, Wei Qin, Xiangyu Zhong, Pengcheng Kang, Ming Wan, Xingming Jiang, Yunfu Cui. Long non-coding RNA UCA1 indicates an unfavorable prognosis and promotes tumorigenesis via regulating AKT/GSK-3β signaling pathway in cholangiocarcinoma. Oncotarget 2017; 8(56): 96203 doi: 10.18632/oncotarget.21884
145
Yi Xu, Yue Yao, Xingming Jiang, Xiangyu Zhong, Zhidong Wang, Chunlong Li, Pengcheng Kang, Kaiming Leng, Daolin Ji, Zhenglong Li, Lining Huang, Wei Qin, Yunfu Cui. SP1-induced upregulation of lncRNA SPRY4-IT1 exerts oncogenic properties by scaffolding EZH2/LSD1/DNMT1 and sponging miR-101-3p in cholangiocarcinoma. Journal of Experimental & Clinical Cancer Research 2018; 37(1) doi: 10.1186/s13046-018-0747-x
146
Sutthiwan Janthamala, Bundit Promraksa, Malinee Thanee, Kunyarat Duenngai, Apinya Jusakul, Sarinya Kongpetch, Ratthaphol Kraiklang, Kidsada Thanee, Porntip Pinlaor, Nisana Namwat, Hideyuki Saya, Anchalee Techasen. Anticancer properties and metabolomic profiling of Shorea roxburghii extracts toward gastrointestinal cancer cell lines. BMC Complementary Medicine and Therapies 2024; 24(1) doi: 10.1186/s12906-024-04479-1
147
B. K. P. Goh, C. B. Rosen. Hilar Cholangiocarcinoma. 2013; : 281 doi: 10.1007/978-94-007-6473-6_26
148
Yohei Ota, Ryusei Matsuyama, Koichi Taniguchi, Michio Ueda, Kazuhisa Takeda, Kuniya Tanaka, Takashi Nakayama, Itaru Endo. Solitary rib recurrence of hilar cholangiocarcinoma 10 years after resection: report of a case. Clinical Journal of Gastroenterology 2013; 6(6): 485 doi: 10.1007/s12328-013-0432-8
149
Gun Ha Kim, Pyeong Hwa Kim, Jin Hyoung Kim, Pyo-Nyun Kim, Hyung Jin Won, Yong Moon Shin, Sang Hyun Choi. Thermal ablation in the treatment of intrahepatic cholangiocarcinoma: a systematic review and meta-analysis. European Radiology 2022; 32(2): 1205 doi: 10.1007/s00330-021-08216-x
150
Divyesh Sejpal. Advancements in Biliary Stenting. Journal of Clinical Gastroenterology 2012; 46(3): 191 doi: 10.1097/MCG.0b013e3182410367
151
Dimitris Zacharoulis, Olga Lazoura, Eleni Sioka, Spyros Potamianos, George Tzovaras, Joanna Nicholls, George Koukoulis, Nagy Habib. Habib EndoHPB: A Novel Endobiliary Radiofrequency Ablation Device. An Experimental Study. Journal of Investigative Surgery 2013; 26(1): 6 doi: 10.3109/08941939.2012.681832
152
Sun Choon Song, Dong Wook Choi, Alfred Wei‐Chieh Kow, Seong Ho Choi, Jin Seok Heo, Woo Seok Kim, Min Jung Kim. Surgical outcomes of 230 resected hilar cholangiocarcinoma in a single centre. ANZ Journal of Surgery 2013; 83(4): 268 doi: 10.1111/j.1445-2197.2012.06195.x
153
Monika Vyas, Dhanpat Jain. A practical diagnostic approach to hepatic masses. Indian Journal of Pathology and Microbiology 2018; 61(1): 2 doi: 10.4103/IJPM.IJPM_578_17
154
Marco Massani, Tommaso Stecca, Bruno Pauletti, Gianpaolo Marte, Cesare Ruffolo, Luca Bonariol, Nicolo’ Bassi. Topics in the Surgery of the Biliary Tree. 2018;  doi: 10.5772/intechopen.75516
155
Sarah JL Payne, Justin Stebbing, Peter Wilson, Sarah Slater. Outcomes in unresectable and locally advanced resected cholangiocarcinoma. Expert Review of Anticancer Therapy 2011; 11(5): 705 doi: 10.1586/era.11.32
156
Nipaporn Ngernyuang, Wunchana Seubwai, Sakda Daduang, Patcharee Boonsiri, Temduang Limpaiboon, Jureerut Daduang. Targeted delivery of 5-fluorouracil to cholangiocarcinoma cells using folic acid as a targeting agent. Materials Science and Engineering: C 2016; 60: 411 doi: 10.1016/j.msec.2015.11.062
157
Jonas Högberg, Magnus Rizell, Ragnar Hultborn, Johanna Svensson, Olof Henrikson, Johan Mölne, Peter Gjertsson, Peter Bernhardt. Heterogeneity of microsphere distribution in resected liver and tumour tissue following selective intrahepatic radiotherapy. EJNMMI Research 2014; 4(1) doi: 10.1186/s13550-014-0048-0
158
Md. Mominur Rhaman, Md. Rezaul Islam, Shopnil Akash, Mobasharah Mim, Md. Noor alam, Eugenie Nepovimova, Martin Valis, Kamil Kuca, Rohit Sharma. Exploring the role of nanomedicines for the therapeutic approach of central nervous system dysfunction: At a glance. Frontiers in Cell and Developmental Biology 2022; 10 doi: 10.3389/fcell.2022.989471
159
Scott R. Gerst, Richard Kinh Gian Do. Blumgart's Surgery of the Liver, Biliary Tract and Pancreas, 2-Volume Set. 2017; : 358 doi: 10.1016/B978-0-323-34062-5.00019-4
160
Antonello A. Romani, Silvia Desenzani, Marina M. Morganti, Maria Cristina Baroni, Angelo F. Borghetti, Paolo Soliani. The BH3-mimetic ABT-737 targets the apoptotic machinery in cholangiocarcinoma cell lines resulting in synergistic interactions with zoledronic acid. Cancer Chemotherapy and Pharmacology 2011; 67(3): 557 doi: 10.1007/s00280-010-1345-6
161
Benjamin L. Yam, Evan S. Siegelman. MR Imaging of the Biliary System. Radiologic Clinics of North America 2014; 52(4): 725 doi: 10.1016/j.rcl.2014.02.011
162
Amy L. Collins, Sylwia Wojcik, James Liu, Wendy L. Frankel, Hansjuerg Alder, Lianbo Yu, Thomas D. Schmittgen, Carlo M. Croce, Mark Bloomston. A Differential MicroRNA Profile Distinguishes Cholangiocarcinoma from Pancreatic Adenocarcinoma. Annals of Surgical Oncology 2014; 21(1): 133 doi: 10.1245/s10434-013-3240-y
163
Matthew V. Kiefer, Marissa Albert, Madeline McNally, Mary Robertson, Weijing Sun, Douglas Fraker, Kim Olthoff, Kathleen Christians, Sam Pappas, William Rilling, Michael C. Soulen. Chemoembolization of intrahepatic cholangiocarcinoma with cisplatinum, doxorubicin, mitomycin C, ethiodol, and polyvinyl alcohol. Cancer 2011; 117(7): 1498 doi: 10.1002/cncr.25625
164
Kai Qu, Si-Nan Liu, Hu-Lin Chang, Chang Liu, Xin-Sen Xu, Rui-Tao Wang, Lei Zhou, Feng Tian, Ji-Chao Wei, Ming-Hui Tai, Fan-Di Meng. Gallbladder Cancer: a Subtype of Biliary Tract Cancer Which is a Current Challenge in China. Asian Pacific Journal of Cancer Prevention 2012; 13(4): 1317 doi: 10.7314/APJCP.2012.13.4.1317
165
Ilenia Bartolini, Matteo Risaliti, Laura Fortuna, Carlotta Agostini, Maria Novella Ringressi, Antonio Taddei, Paolo Muiesan. Current management of intrahepatic cholangiocarcinoma: from resection to palliative treatments. Radiology and Oncology 2020; 54(3): 263 doi: 10.2478/raon-2020-0045
166
Eveline Boucher, Marc Pracht, Catherine Roux, Karim Boudjema, Jean-Luc Raoul. Adjuvant treatment after resection of biliary-tract cancer: yes or no?. Oncology Reviews 2010; 4(3): 167 doi: 10.1007/s12156-010-0047-y
167
Joost W. Wijlemans, Karel J. Van Erpecum, Marnix G.E.H. Lam, Beatrijs A. Seinstra, Maarten L.J. Smits, Bernard A. Zonnenberg, Maurice A.A.J. Van Den Bosch. Trans-arterial 90yttrium radioembolization for patients with unresectable tumors originating from the biliary tree. Annals of Hepatology 2011; 10(3): 349 doi: 10.1016/S1665-2681(19)31549-2
168
Hans Francis Schoellhammer, Yuman Fong, Gagandeep Singh. Blumgart's Surgery of the Liver, Biliary Tract and Pancreas, 2-Volume Set. 2017; : 818 doi: 10.1016/B978-0-323-34062-5.00051-0
169
Suzanne C. Schiffman, Michael R. Nowacki, Lena Spencer, Kelly M. McMasters, Charles R. Scoggins, Robert C.G. Martin. Molecular factors associated with recurrence and survival following hepatectomy in patients with intrahepatic cholangiocarcinoma: A guide to adjuvant clinical trials. Journal of Surgical Oncology 2014; 109(2): 98 doi: 10.1002/jso.23459
170
Everson L. A. Artifon, Décio Sampaio Couto Júnior, Paulo Sakai. Tratamento endoscópico das lesões biliares. Revista do Colégio Brasileiro de Cirurgiões 2010; 37(2): 143 doi: 10.1590/S0100-69912010000200012
171
HyungJoo Baik, Sang Hyuk Seo, Kwang Hee Kim, Moon Young Choi, Yo-Han Park, Chang Soo Choi. Treatment of advanced stage cholangiocarcinoma: Systemic therapy may be the starting step for radical surgery. Korean Journal of Clinical Oncology 2018; 14(1): 62 doi: 10.14216/kjco.18011
172
Sutthiwan Janthamala, Apinya Jusakul, Sarinya Kongpetch, Phongsaran Kimawaha, Poramate Klanrit, Watcharin Loilome, Nisana Namwat, Anchalee Techasen. Arctigenin inhibits cholangiocarcinoma progression by regulating cell migration and cell viability via the N-cadherin and apoptosis pathway. Naunyn-Schmiedeberg's Archives of Pharmacology 2021; 394(10): 2049 doi: 10.1007/s00210-021-02123-0
173
Ana F. Brito, Ana M. Abrantes, João C. Encarnação, José G. Tralhão, Maria F. Botelho. Cholangiocarcinoma: from molecular biology to treatment. Medical Oncology 2015; 32(11) doi: 10.1007/s12032-015-0692-x
174
Heba Said Ellaban, Mohamed R. El-Kholy, Tarek F. Abdellah, Mohamed Saied Abdelgawad. Diagnostic performance of ADC value in histopathological grading of mass-forming cholangiocarcinoma. Egyptian Journal of Radiology and Nuclear Medicine 2022; 53(1) doi: 10.1186/s43055-022-00926-6
175
Ana P. Borges, António V. Silva, Paulo Donato. Comparison between Suprapapillary and Transpapillary Uncovered Self-Expandable Metallic Stent Placement for Perihilar Cholangiocarcinoma. Journal of Vascular and Interventional Radiology 2023; 34(8): 1400 doi: 10.1016/j.jvir.2023.03.031
176
Keith D. Lillemoe, Michael G. House. Handbook of Liver Disease. 2012; : 460 doi: 10.1016/B978-1-4377-1725-9.10034-6
177
Ban Seok Lee, Byung Hyo Cha, Eun‐Cheol Park, Jaehoon Roh. Risk factors for perihilar cholangiocarcinoma: A hospital‐based case–control study. Liver International 2015; 35(3): 1048 doi: 10.1111/liv.12618
178
Olaguoke Akinwande, Veer Shah, Abigail Mills, Christopher Noda, Eric Weiner, Gretchen Foltz, Nael Saad. Chemoembolization versus radioembolization for the treatment of unresectable intrahepatic cholangiocarcinoma in a single institution image-based efficacy and comparative toxicity. Hepatic Oncology 2017; 4(3): 75 doi: 10.2217/hep-2017-0005
179
Zhiliang Wu, Thidarut Boonmars, Isao Nagano, Sirintip Boonjaraspinyo, Somchai Pinlaor, Chawalit Pairojkul, Yaovalux Chamgramol, Yuzo Takahashi. Alteration of galectin-1 during tumorigenesis of Opisthorchis viverrini infection-induced cholangiocarcinoma and its correlation with clinicopathology. Tumor Biology 2012; 33(4): 1169 doi: 10.1007/s13277-012-0360-0
180
Akihito Okubo, Sae Matsumoto, Hiroyasu Tamamura, Yoshitaka Sato, Satoko Asahi, Hitoshi Tatebe, Kazutaka Yamamoto, Keiichiro Matsushita, Makoto Sasaki, Yoshikazu Maeda, Yuji Tameshige, Hajime Sunagozaka, Hiroyuki Aoyagi, Satoshi Shibata, Shigeyuki Takamatsu, Satoshi Kobayashi. Respiratory-gated proton beam therapy for intrahepatic cholangiocarcinoma without fiducial markers. Radiation Oncology 2024; 19(1) doi: 10.1186/s13014-024-02550-2
181
Harsha Moole, Sirish Dharmapuri, Abhiram Duvvuri, Sowmya Dharmapuri, Raghuveer Boddireddy, Vishnu Moole, Prathyusha Yedama, Naveen Bondalapati, Achuta Uppu, Charan Yerasi. Endoscopic versus Percutaneous Biliary Drainage in Palliation of Advanced Malignant Hilar Obstruction: A Meta-Analysis and Systematic Review. Canadian Journal of Gastroenterology and Hepatology 2016; 2016: 1 doi: 10.1155/2016/4726078
182
Dushyant Jaiswal, Chirag Bhansali, Abhishek Shitole, Vineet Kumar, Ameya Bindu, Mayur Mantri, Saumya Mathews, Vinay Kant Shankhdhar. Utility of Microvascular Reconstruction in Gastrointestinal Cancer Surgery During Complex Resections and Emergency Salvage. Indian Journal of Surgical Oncology 2024; 15(3): 513 doi: 10.1007/s13193-024-01942-w
183
Manuela Gatto, Maria Consiglia Bragazzi, Rossella Semeraro, Cristina Napoli, Raffaele Gentile, Alessia Torrice, Eugenio Gaudio, Domenico Alvaro. Cholangiocarcinoma: Update and future perspectives. Digestive and Liver Disease 2010; 42(4): 253 doi: 10.1016/j.dld.2009.12.008
184
T Okusaka, K Nakachi, A Fukutomi, N Mizuno, S Ohkawa, A Funakoshi, M Nagino, S Kondo, S Nagaoka, J Funai, M Koshiji, Y Nambu, J Furuse, M Miyazaki, Y Nimura. Gemcitabine alone or in combination with cisplatin in patients with biliary tract cancer: a comparative multicentre study in Japan. British Journal of Cancer 2010; 103(4): 469 doi: 10.1038/sj.bjc.6605779
185
Linqi Guo, Yu Zhou, Ying Chen, Huawei Sun, Yue Wang, Yikun Qu. LncRNA ASAP1-IT1 positively modulates the development of cholangiocarcinoma via hedgehog signaling pathway. Biomedicine & Pharmacotherapy 2018; 103: 167 doi: 10.1016/j.biopha.2018.04.015
186
Kyun Woo Park, Eun-Seon Jung, Dong-Gu Kim, Young-Kyung Yoo, Tae-Ho Hong, In Seok Lee, Yoon Ho Koh, Ji-Hoon Kim, Myung Ah Lee. ERCC1 Can Be a Prognostic Factor in Hilar Cholangiocarcinoma and Extrahepatic Bile Duct Cancer, But Not in Intrahepatic Cholangiocarcinoma. Cancer Research and Treatment 2013; 45(1): 63 doi: 10.4143/crt.2013.45.1.63
187
Dong Liu, Junxiao Wang, Zhenhu Ma, Ning Zhang, Yun Zhao, Xiang Yang, Zhenyu Wen, Hui Xie. Treatment of unresectable intrahepatic cholangiocarcinoma using transarterial chemoembolisation with irinotecan-eluting beads: analysis of efficacy and safety. CardioVascular and Interventional Radiology 2022; 45(8): 1092 doi: 10.1007/s00270-022-03108-z
188
Chang-Sup Lim, Jin-Young Jang, Seung Eun Lee, Mee Joo Kang, Sun-Whe Kim. Reappraisal of Hepatopancreatoduodenectomy as a Treatment Modality for Bile Duct and Gallbladder Cancer. Journal of Gastrointestinal Surgery 2012; 16(5): 1012 doi: 10.1007/s11605-012-1826-5
189
Jing Xu, Dajing Li, Xiaowu Li, Zipei Liu, Tianyu Li, Peng Jiang, Qiang He, Feng Tian, Yang Gao, Dechun Wang, Shuguang Wang. 67 laminin receptor promotes the malignant potential of tumour cells up-regulating lysyl oxidase-like 2 expression in cholangiocarcinoma. Digestive and Liver Disease 2014; 46(8): 750 doi: 10.1016/j.dld.2014.03.017
190
Tatsuaki Sumiyoshi, Yasuo Shima, Takehiro Okabayashi, Yuji Negoro, Yasuhiro Shimada, Jun Iwata, Manabu Matsumoto, Yasuhiro Hata, Yoshihiro Noda, Kenta Sui, Taijiro Sueda. Chemoradiotherapy for Initially Unresectable Locally Advanced Cholangiocarcinoma. World Journal of Surgery 2018; 42(9): 2910 doi: 10.1007/s00268-018-4558-1
191
Keun Soo Ahn, Koo Jeong Kang, Yu Na Kang, Yong Hoon Kim, Tae-Seok Kim. Confinement to the intrapancreatic bile duct is independently associated with a better prognosis in extrahepatic cholangiocarcinoma. BMC Gastroenterology 2016; 16(1) doi: 10.1186/s12876-016-0444-1
192
Mai-Lan Ho, Christine M. Peterson, Vamsidhar R. Narra. Abdominal Imaging. 2011; : 890 doi: 10.1016/B978-1-4160-5449-8.00086-X
193
D. Habermehl, K. Lindel, S. Rieken, K. Haase, B. Goeppert, M.W. Büchler, P. Schirmacher, T. Welzel, J. Debus, S.E. Combs. Chemoradiation in patients with unresectable extrahepatic and hilar cholangiocarcinoma or at high risk for disease recurrence after resection. Strahlentherapie und Onkologie 2012; 188(9): 795 doi: 10.1007/s00066-012-0099-y
194
Kang Won Lee, Jae Min Lee, Hyuk Soon Choi, Eun Sun Kim, Bora Keum, Yeon Seok Seo, Yoon Tae Jeen, Soon Ho Um, Hong Sik Lee, Hoon Jai Chun, Chang Duck Kim, Chi Hyuk Oh, Hong Bae Kim. Novel Ablation Therapy Using Endoscopic Irreversible Electroporation in the Bile Duct: A Pilot Animal Study. Clinical Endoscopy 2021; 54(3): 413 doi: 10.5946/ce.2020.126
195
C. Damiano Gadaleta, Girolamo Ranieri. Trans-arterial chemoembolization as a therapy for liver tumours: New clinical developments and suggestions for combination with angiogenesis inhibitors. Critical Reviews in Oncology/Hematology 2011; 80(1): 40 doi: 10.1016/j.critrevonc.2010.10.005
196
S. H. Y. Lau, W. Y. Lau. Hilar Cholangiocarcinoma. 2013; : 187 doi: 10.1007/978-94-007-6473-6_17
Write to the Help Desk
© 2004-2024 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

California Corporate Number: 3537345